On June 11, 2014, an objection to the motion for approval of procedures regarding voting on a plan of reorganization or liquidation was filed in the bankruptcy case of Neogenix Oncology, Inc. and its affiliates.
The filing was assigned docket number 0 and is described on the court’s official docket as follows:
Hearing Set On (related document(s) Opposition filed by Stockholder Henry Morgan,  Objection filed by Interested Party U.S. Securities and Exchange Commission,  Objection filed by U.S. Trustee US Trustee – Greenbelt,  Objection filed by Creditor Peter Gordon, Creditor Anne Gordon,  Support Document filed by Stockholder Henry Morgan). Hearing scheduled for 7/1/2014 at 02:00 PM at Courtroom 3-E, Greenbelt – Judge Catliota. (Devine, Ellen)
Neogenix Oncology, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on July 23, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Maryland. The case number for the lead bankruptcy case is 12-23557. The bankruptcy case is currently assigned to United States Bankruptcy Judge Thomas Catliota. The law firm of Greenberg Traurig, LLP is acting as lead bankruptcy counsel to Neogenix Oncology, Inc. in the bankruptcy case.